Overview

Tafenoquine/Chloroquine DDI Study

Status:
Completed
Trial end date:
2009-08-26
Target enrollment:
Participant gender:
Summary
DDI study of Tafenoquine and Chloroquine
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Collaborator:
Medicines for Malaria Venture
Treatments:
Chloroquine
Chloroquine diphosphate
Tafenoquine